Fast-growing Brokerage Futu Lifts Off With Fanfare, Up 44% Early
Futu Holdings Ltd. (Nasdaq: FHL) soared 44 percent in its first minutes of trading on the Nasdaq Friday as it raised $90 million in its initial public offering.
The Hong Kong-based fully digitized brokerage company priced its shares at the top end of the expected range of $10 to $12 late Thursday and jumped to $16.79 per American depositary share as it lifted off before noon today. It thus became the first Asian company to become publicly traded in New York this year.
Futu's stock soared more than 44 percent as it lifted off on the Nasdaq Friday
(Source: Thomson Reuters Eikon)
Backed by Chinese conglomerate Tencent Holdings Ltd. (HKEX: 0700), Futu aims to provide online stock trading services with low fees and live feeds. Unlike other platforms, the company allows mainland Chinese investors to trade stocks in Hong Kong and the United States. It is reported that Futu Securities was among the top five brokerage companies in Hong Kong with more than 80 percent of users from mainland China.
(Source: Nasdaq Twitter)
The fast-growing company said in a filing with the U.S. Securities and Exchange Commission last month that its revenue for the year through December reached $103.6 million, an increase of 159 percent from the preceding year. Net income was $17.7 million, or 1 cent per share, in contrast to a net loss of $1 million in 2017.
Futu stated that it plans to use the proceeds of its public offering for "general corporate purposes, including research and development, working capital needs, and increased regulatory capital requirements of the HK SFC and regulatory authorities in other jurisdictions as a result of our business expansion."
Underwriters on the deal are Goldman Sachs (Asia) LLC, UBS Securities LLC, Credit Suisse Securities (USA) LLC, HSBC Securities (USA) Inc., and BOCI Asia Ltd.
Bright Scholar's Shares Slip 2% on Losses, Market Uncertainty
Pingtan Stock Plunges 14% on Weak Sales, Net Income Drop
Tencent Music's Revenue Growth Offset by Decline in Sublicensing
500.com Posts Disappointing Revenue for Third Quarter
Alibaba Sets New Record for Sales on Singles Day
Cellular Biomedicine Up 1% on Buyout Proposal